-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CQdC8sDTA5DB2HUsQg7wdcoYVSMyCZffqsyCLnm0mSclbEWMBa1Z2+d+4/j4AiCH z7xiiDsklErbvsrm1cid0w== 0000897485-01-000060.txt : 20010313 0000897485-01-000060.hdr.sgml : 20010313 ACCESSION NUMBER: 0000897485-01-000060 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20000309 FILED AS OF DATE: 20010312 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NEOTHERAPEUTICS INC CENTRAL INDEX KEY: 0000831547 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 930979187 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: SEC FILE NUMBER: 000-28782 FILM NUMBER: 1565951 BUSINESS ADDRESS: STREET 1: 157 TECHNOLOGY DR STREET 2: STE J-821 CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 9497886700 MAIL ADDRESS: STREET 1: 157 TECHNOLOGY DR STREET 2: STE J-821 CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: AMERICUS FUNDING CORP DATE OF NAME CHANGE: 19920703 COMPANY DATA: COMPANY CONFORMED NAME: KELLOGG PETER R CENTRAL INDEX KEY: 0000897485 STANDARD INDUSTRIAL CLASSIFICATION: [] OWNER FILING VALUES: FORM TYPE: 3 BUSINESS ADDRESS: STREET 1: C/O SPEAR LEEDS & KELLOGG STREET 2: 120 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10271 BUSINESS PHONE: 2124337070 MAIL ADDRESS: STREET 1: 120 BROADWAY STREET 2: C/O SPEAR LEEDS & KELLOGG CITY: NEW YORK STATE: NY ZIP: 10271 3 1 0001.txt U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES FORM 3 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 1. Name and Address of Reporting Person Kellogg, Peter R. c/o Spear, Leeds & Kellogg 120 Broadway New York, New York 10271 2. Date of Event Requiring Statement March 9, 2001 3. IRS or Social Security Number of Reporting Person (Voluntary) 4. Issuer Name and Ticker or Trading Symbol: Neotherapeutics, Inc. ("NEOT") 5. Relationship of Reporting Person to Issuer (Check all applicable) ___ Director 10% Owner ___ Officer ___ Other (give title below) (specify below) 6. If Amendment, Date of Original (Month/Day/Year) Table I - Non-Derivative Securities Beneficially Owned 1. Title of Security (Instr. 4): Common Stock, Par Value $.01 per share 2. Amount of Securities Beneficially Owned (Instr. 4) 2,194,900 3. Ownership Form: Direct (D)or Indirect (I) (Instr. 5) I (1) (2) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 4) ___________ 2. Date Exercisable and Expiration Date (Month/Day/Year) ___________ 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) ___________ 4. Conversion or Exercise Price of Derivative Security ___________ 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) ___________ 6. Nature of Indirect Beneficial Ownership (Instr. 5) ___________ Explanation of Responses: 1. IAT Reinsurance Syndicate Ltd, a Bermuda Corporation of which Mr. Kellogg is sole holder of voting stock. 2. Mr. Kellogg disclaims beneficial ownership of these shares. **Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). March 12, 2001 Peter R. Kellogg Date Peter R. Kellogg -----END PRIVACY-ENHANCED MESSAGE-----